1. Home
  2. AVY vs CYTK Comparison

AVY vs CYTK Comparison

Compare AVY & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avery Dennison Corporation

AVY

Avery Dennison Corporation

HOLD

Current Price

$181.82

Market Cap

12.8B

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$61.48

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVY
CYTK
Founded
1935
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8B
10.7B
IPO Year
1994
2004

Fundamental Metrics

Financial Performance
Metric
AVY
CYTK
Price
$181.82
$61.48
Analyst Decision
Buy
Strong Buy
Analyst Count
11
23
Target Price
★ $199.50
$109.40
AVG Volume (30 Days)
535.5K
★ 1.8M
Earning Date
10-29-2026
11-04-2026
Dividend Yield
★ 2.17%
N/A
EPS Growth
★ 0.69
N/A
EPS
★ 4.85
N/A
Revenue
N/A
★ $13,368,000.00
Revenue This Year
$5.54
$72.63
Revenue Next Year
$3.17
$181.06
P/E Ratio
$37.98
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$152.42
$57.92
52 Week High
$199.54
$88.31

Technical Indicators

Market Signals
Indicator
AVY
CYTK
Relative Strength Index (RSI) 66.47 37.55
Support Level $166.02 $59.21
Resistance Level $186.84 $66.63
Average True Range (ATR) 3.49 1.98
MACD 1.53 0.33
Stochastic Oscillator 81.71 31.89

Price Performance

Historical Comparison
AVY
CYTK

About AVY Avery Dennison Corporation

Avery Dennison Corp provides materials science and digital identification solutions, offering labeling and functional materials, RFID inlays and tags, software connecting physical and digital, and products that enhance packaging and customer experience. Serving industries including retail, apparel, e-commerce, logistics, food, pharmaceuticals, and automotive it operates through two reportable segments: Materials Group, which manufactures and sells pressure-sensitive label materials, graphics, reflective products, performance tapes, and other adhesive solutions, and earns the majority of revenue; and Solutions Group, which provides brand and price tickets, tags, labels with RFID inlays, and related services, supplies, and equipment.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: